Msds.egeneralmedical.com

Material Safety Data Sheet
acc. to ISO/DIS 11014
1 Identification of substance:
· Product name: Cefpodoxime CPD-10
· Catalog number: 231674

· Manufacturer/Supplier:
BD Diagnostic Systems7 Loveton CircleSparks, MD 21152Tel: (410) 771-0100 or (800) 638-8663 · Information department: Technical Services
· Emergency information:

In case of a chemical emergency, spill, fire, exposure, or accident contact BD Diagnostic Systems at(410)771-0100 or (800)638-8663, or ChemTrec at (800)424-9300. 2 Composition/Data on components:
· Chemical characterization:
· CAS No. Description:

3 Hazards identification
· Hazard description:
This product contains no hazardous constituents, or the concentration of all chemical constituents arebelow the regulatory threshold limits described by Occupational Safety Health Administration HazardCommunication Standard 29 CFR 1910.1200 and the European Directive 91/155/EEC, and 93/112/EC. · NFPA ratings (scale 0-4)
4 First aid measures
· General information No special measures required.
· After inhalation Seek medical treatment in case of complaints.
· After skin contact Immediately wash with water and soap and rinse thoroughly.
· After eye contact

Rinse opened eye for several minutes under running water. If symptoms persist, consult a doctor. · After swallowing If symptoms persist consult doctor.
· Information for doctor Show this product label or this MSDS.

5 Fire fighting measures
· Suitable extinguishing agents
CO2, ABC multipurpose dry chemical or water spray. Fight larger fires with water spray or alcoholresistant foam. Material Safety Data Sheet
acc. to ISO/DIS 11014
Product name: Cefpodoxime CPD-10
· Protective equipment: No special measures required.
6 Accidental release measures
· Person-related safety precautions: Not required.
· Measures for environmental protection: Wipe up with damp sponge or mop.
· Measures for cleaning/collecting: No special measures required.
· Additional information: No dangerous substances are released.

7 Handling and storage
· Handling
· Information for safe handling: Keep receptacles tightly sealed.
· Information about protection against explosions and fires: No special measures required.

· Storage
· Requirements to be met by storerooms and receptacles: No special requirements.
· Information about storage in one common storage facility: Store away from oxidizing agents.
· Further information about storage conditions: Store in cool, dry conditions in well sealed containers.

8 Exposure controls and personal protection
· Additional information about design of technical systems: No further data; see item 7.
· Components with limit values that require monitoring at the workplace: Not required.
· Additional information: The lists that were valid during the creation were used as basis.

· Personal Protective Equipment
· General protective and hygienic measures

The usual precautionary measures for handling chemicals should be followed. · Breathing equipment: Not required.
· Protection of hands:

Chemical resistant gloves (i.e. nitrile, or equivalent). · Eye protection: Safety glasses
· Body protection: Protective work clothing (lab coat).

9 Physical and chemical properties:
· General Information
Form:
Color:
According to product specification Odor:
· Change in condition
· Melting point/Melting range: Not determined
Material Safety Data Sheet
acc. to ISO/DIS 11014
Product name: Cefpodoxime CPD-10
· Boiling point/Boiling range: Not determined
· Flash point:
· Flammability (solid, gaseous) Product is not flammable.
· Danger of explosion:
Product does not present an explosion hazard. · Density:
· Solubility in / Miscibility with
Water:
· Solids content:
10 Stability and reactivity
· Thermal decomposition / conditions to be avoided:
No decomposition if used according to specifications. · Dangerous reactions No dangerous reactions known
· Dangerous products of decomposition: No dangerous decomposition products known.

11 Toxicological information
· Acute toxicity:
· Primary irritant effect:
· on the skin: No irritating effect.
· on the eye: No irritating effect.
· Sensitization: Sensitizing effect through inhalation is possible with prolonged exposure.
· Additional toxicological information:

When used and handled according to specifications, the product does not have any harmful effectsaccording to our experience and the information provided to us.
This product contains antibiotics. People with known or suspected allergies to antibiotics should useappropriate safety precautions when handling. People that are allergic to antibiotics may experienceeye, skin, and respiratory irritation.
The substance is not subject to classification.
12 Ecological information:
· Ecotoxical effects:
· Other information:

The ecological effects have not been thoroughly investigated, but currently none have been identified. · General notes: Generally not hazardous for water.
13 Disposal considerations
· Product:
· Recommendation

Smaller quantities can be disposed of with solid waste.
Dispose of material in accordance with federal (40 CFR 261.3), state and local requirements.
Material Safety Data Sheet
acc. to ISO/DIS 11014
Product name: Cefpodoxime CPD-10
This product is not considered a RCRA hazardous waste. · Uncleaned packagings:
· Recommendation: Disposal must be made according to state and federal regulations.
· Recommended cleansing agent: Water, if necessary with cleansing agents.

14 Transport information
· DOT regulations:
· Hazard class:

· Land transport ADR/RID (cross-border)
· ADR/RID class:

· Maritime transport IMDG:
· IMDG Class:

· Marine pollutant: No
· Air transport ICAO-TI and IATA-DGR:
· ICAO/IATA Class: -

· Transport/Additional information:
If a dashed line appears in the Hazard Class section for the type of transportation, this indicates theproduct is not regulated for transportation. However, if a Hazard Class Number is listed the product isregulated. 15 Regulations
· SARA Section 355 (extremely hazardous substances)
· SARA Section 313 (specific toxic chemical listings)
· TSCA (Toxic Substances Control Act)
· California Proposition 65 - Chemicals known to cause cancer
· California Proposition 65 - Chemicals known to cause reproductive toxicity for females:
· California Proposition 65 - Chemicals known to cause reproductive toxicity for males:
· California Proposition 65 - Chemicals known to cause developmental toxicity:
· Carcinogenicity categories
· IARC (International Agency for Research on Cancer)
Material Safety Data Sheet
acc. to ISO/DIS 11014
Product name: Cefpodoxime CPD-10
· NTP (National Toxicology Program)
· TLV (Threshold Limit Value established by ACGIH)
· Product related hazard information:
Observe the general safety regulations when handling chemicalsThe substance is not subject to classification according to the sources of literature known to us.
The product is not subject to identification regulations pertaining to regulations on hazardous materials.
· National regulations
· Water hazard class: Generally not hazardous for water.
16 Other information:
To the best of our knowledge, the information contained herein is accurate. However, neitherBecton,Dickinson and Company or any of its subsidiaries assumes any liabilities whatsoever for theaccuracy or completeness of the information contained herein. Final determination of suitability of anymaterial is the sole responsibility of the user. All materials may present unknown hazards and should beused with caution. Although certain hazards are described herein, we cannot guarantee that these arethe only hazards that exist. · Department issuing MSDS: Safety and Environment Department
· Contact: Technical Service Representative

Source: http://msds.egeneralmedical.com/90002-497.pdf

mmt.hu

Raloxifene and cardioprotection in early postmenopausal women The Raloxifene Use for The Heart (RUTH) trial results were published in 2004 [1]. This was a randomized, double-blind, placebo-controlled study which recruited 10,101 women above the age of 55 years (mean age 67.5 years), with established coronary artery disease (CAD) or at high risk for CAD. Women were followed for a median period

greenlab.npih.ucla.edu

Psychopharmacology (2006) 187:312–320DOI 10.1007/s00213-006-0428-xThe neurocognitive effects of aripiprazole: an open-labelcomparison with olanzapineRobert S. Kern & Michael F. Green &Barbara A. Cornblatt & J. Randall Owen &Robert D. McQuade & William H. Carson & Mirza Ali &Ron MarcusReceived: 26 November 2005 / Accepted: 3 May 2006 / Published online: 30 June 2006

Copyright © 2010 Health Drug Pdf